%0 Conference Paper
%D 2018
%I NEPHROLOGY
%P 25 - 25
%T ASSESSING BASELINE MEDICATION USE IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF THE SHARP-ER STUDY
%U http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1